{"id":"vas203","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypertension"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Nausea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"VAS203 selectively inhibits nitric oxide synthase, an enzyme that produces nitric oxide. Excessive nitric oxide production during ischemic stroke contributes to neuronal damage through oxidative stress and inflammation. By reducing nitric oxide levels, VAS203 aims to limit secondary brain injury and improve neurological outcomes in acute ischemic stroke patients.","oneSentence":"VAS203 is a nitric oxide synthase inhibitor that reduces nitric oxide production to protect against ischemic brain injury.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:54:42.505Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute ischemic stroke"}]},"trialDetails":[{"nctId":"NCT02794168","phase":"PHASE3","title":"Efficacy of VAS203 (Ronopterin) in Patients With Moderate and Severe Traumatic Brain Injury","status":"COMPLETED","sponsor":"veriNOS operations GmbH","startDate":"2016-06","conditions":"Traumatic Brain Injury","enrollment":224},{"nctId":"NCT02992236","phase":"PHASE1","title":"Effects of the NO-synthase Inhibitor VAS203 on Renal Function in Healthy Volunteers","status":"COMPLETED","sponsor":"veriNOS operations GmbH","startDate":"2015-08","conditions":"Renal Function Impairment in Healthy Volunteers","enrollment":16},{"nctId":"NCT02012582","phase":"PHASE2","title":"Phase 2 a Study to Assess Safety and Pharmacokinetics of VAS203 in Patients With Traumatic Brain Injury","status":"COMPLETED","sponsor":"veriNOS operations GmbH","startDate":"2009-11","conditions":"Traumatic Brain Injury","enrollment":32}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Ronopterin"],"phase":"phase_3","status":"active","brandName":"VAS203","genericName":"VAS203","companyName":"veriNOS operations GmbH","companyId":"verinos-operations-gmbh","modality":"Small molecule","firstApprovalDate":"","aiSummary":"VAS203 is a nitric oxide synthase inhibitor that reduces nitric oxide production to protect against ischemic brain injury. Used for Acute ischemic stroke.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}